Data / Drug companies / Neuland Laboratories Limited
Neuland Laboratories Limited: 65 products in the FDA NDC directory, labeler code 58032
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Neuland Laboratories Limited (labeler code 58032) lists 65 products in the FDA National Drug Code Directory. By type: 65 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 18, 2026.
The request: Watch Neuland Laboratories Limited (FDA labeler code 58032): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 58032
- Products in commercial distribution
- 65
- Packages
- 69
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- October 1, 2005
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 64 | 98.5% |
| Bulk ingredients for compounding | 1 | 1.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 65 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 64 | 98.5% |
| Solution | 1 | 1.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ipratropium bromide | 58032-1037 | Powder | Bulk ingredients for compounding | May 18, 2026 |
| Edoxaban tosylate monohydrate | 58032-3005 | Powder | Bulk ingredients | December 19, 2024 |
| Bempedoic acid | 58032-2033 | Powder | Bulk ingredients | April 12, 2023 |
| Mirabegron | 58032-2040 | Powder | Bulk ingredients | March 30, 2023 |
| Tafamidis (form-4) | 58032-1031 | Powder | Bulk ingredients | March 30, 2023 |
| Voxelotor form-i | 58032-1030 | Powder | Bulk ingredients | March 30, 2023 |
| Voxelotor adipic acid co-crystal | 58032-1029 | Powder | Bulk ingredients | March 30, 2023 |
| Xanomeline tartrate | 58032-3003 | Powder | Bulk ingredients | March 17, 2023 |
| Viloxazine hydrochloride | 58032-3002 | Powder | Bulk ingredients | March 17, 2023 |
| Ciprofloxacin hydrochloride | 58032-3001 | Powder | Bulk ingredients | March 17, 2023 |
| Tafamidis meglumine | 58032-2037 | Powder | Bulk ingredients | March 31, 2022 |
| Elagolix sodium | 58032-1028 | Powder | Bulk ingredients | March 31, 2022 |
| Donepezil base | 58032-1026 | Powder | Bulk ingredients | October 22, 2020 |
| Edaravone | 58032-2035 | Powder | Bulk ingredients | September 15, 2020 |
| Levetiracetam | 58032-0132 | Powder | Bulk ingredients | March 6, 2020 |
| Ticagrelor | 58032-2032 | Powder | Bulk ingredients | November 13, 2019 |
| Sugammadex | 58032-2031 | Powder | Bulk ingredients | November 13, 2019 |
| Indacaterol maleate | 58032-1025 | Powder | Bulk ingredients | November 13, 2019 |
| Rotigotine | 58032-1022 | Powder | Bulk ingredients | November 22, 2018 |
| Apremilast | 58032-2030 | Powder | Bulk ingredients | November 14, 2018 |
| Rabeprazole sodium monohydrate | 58032-1023 | Powder | Bulk ingredients | October 25, 2018 |
| Paliperidone palmitate (sterile) | 58032-1021 | Solution | Bulk ingredients | October 25, 2018 |
| Aripiprazole lauroxil | 58032-1020 | Powder | Bulk ingredients | October 25, 2018 |
| Acetyl-gly-ala-gln-phe-ser-lys-thr-ala-lys-oh. acetate (bio-11006) | 58032-1016 | Powder | Bulk ingredients | October 25, 2018 |
| Dapiprazole hydrochloride | 58032-1009 | Powder | Bulk ingredients | October 25, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.